| Date Filed | Type | Description |
| 10/02/2023 |
3
| KIRBY J SCOTT (Director) has filed a Form 3 on CVS HEALTH Corp |
| 10/02/2023 |
4
| KIRBY J SCOTT (Director) has filed a Form 4 on CVS HEALTH Corp|
Txns:
| Granted 299 shares
@ $69.82, valued at
$20.9k
|
|
| 08/04/2023 |
4
| Clark James David (SVP, Cont & Chief Acct Officer) has filed a Form 4 on CVS HEALTH Corp|
Txns:
| Sold 2,631 shares
@ $74.79, valued at
$196.8k
Sold 23,128 shares
@ $74.94, valued at
$1.7M
|
|
| 05/19/2023 |
4
| MILLON JEAN PIERRE (Director) has filed a Form 4 on CVS HEALTH Corp|
Txns:
| Granted 1,437 shares
@ $69.31, valued at
$99.6k
|
|
| 05/19/2023 |
4
| Finucane Anne A. (Director) has filed a Form 4 on CVS HEALTH Corp|
Txns:
| Granted 1,437 shares
@ $69.31, valued at
$99.6k
|
|
| 05/19/2023 |
4
| DEPARLE NANCY ANN (Director) has filed a Form 4 on CVS HEALTH Corp|
Txns:
| Granted 1,437 shares
@ $69.31, valued at
$99.6k
|
|
| 05/19/2023 |
4
| Balser Jeffrey R. (Director) has filed a Form 4 on CVS HEALTH Corp|
Txns:
| Granted 1,329 shares
@ $69.31, valued at
$92.1k
|
|
| 05/19/2023 |
4
| AGUIRRE FERNANDO (Director) has filed a Form 4 on CVS HEALTH Corp|
Txns:
| Granted 1,329 shares
@ $69.31, valued at
$92.1k
|
|
| 05/19/2023 |
4
| SCHAPIRO MARY L (Director) has filed a Form 4 on CVS HEALTH Corp|
Txns:
| Granted 1,329 options to buy
@ $0 |
|
| 05/19/2023 |
4
| LUDWIG EDWARD J (Director) has filed a Form 4 on CVS HEALTH Corp|
Txns:
| Granted 2,069 options to buy
@ $0 |
|
| 05/19/2023 |
4
| FARAH ROGER N (Director) has filed a Form 4 on CVS HEALTH Corp|
Txns:
| Granted 3,917 options to buy
@ $0 |
|
| 05/19/2023 |
4
| BROWN C DAVID II (Director) has filed a Form 4 on CVS HEALTH Corp|
Txns:
| Granted 1,437 options to buy
@ $0 |
|
| 05/19/2023 |
4
| DECOUDREAUX ALECIA A (Director) has filed a Form 4 on CVS HEALTH Corp|
Txns:
| Granted 1,329 options to buy
@ $0 |
|
| 05/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2023 |
4
| Shah Prem S (EVP and Co-President of Retail) has filed a Form 4 on CVS HEALTH Corp|
Txns:
| Paid exercise price by delivering 3,221 shares
@ $74.31, valued at
$239.4k
Granted 89,073 options to buy
@ $74.31, valued at
$6.6M
|
|
| 04/04/2023 |
4
| PELUSO MICHELLE A (EVP and Co-President of Retail) has filed a Form 4 on CVS HEALTH Corp|
Txns:
| Paid exercise price by delivering 98,299 shares
@ $74.31, valued at
$7.3M
Granted 89,073 options to buy
@ $74.31, valued at
$6.6M
|
|
| 04/04/2023 |
4
| Mandadi Tilak (EVP, Chief Technology Officer) has filed a Form 4 on CVS HEALTH Corp|
Txns:
| Granted 96,496 options to buy
@ $74.31, valued at
$7.2M
|
|
| 04/04/2023 |
4
| Lynch Karen S (President and CEO) has filed a Form 4 on CVS HEALTH Corp|
Txns:
| Paid exercise price by delivering 93,677 shares
@ $74.31, valued at
$7M
Granted 244,952 options to buy
@ $74.31, valued at
$18.2M
|
|
| 04/04/2023 |
4
| Khichi Samrat S. (EVP, CPO and General Counsel) has filed a Form 4 on CVS HEALTH Corp|
Txns:
| Granted 66,805 options to buy
@ $74.31, valued at
$5M
|
|
| 04/04/2023 |
4
| Joyner J. David (EVP&President-PharmacyServices) has filed a Form 4 on CVS HEALTH Corp|
Txns:
| Granted 51,959 options to buy
@ $74.31, valued at
$3.9M
|
|
| 04/04/2023 |
4
| Havanec Laurie P. (EVP and Chief People Officer) has filed a Form 4 on CVS HEALTH Corp|
Txns:
| Granted 51,959 options to buy
@ $74.31, valued at
$3.9M
|
|
| 04/04/2023 |
4
| GUERTIN SHAWN M (EVP & CFO) has filed a Form 4 on CVS HEALTH Corp|
Txns:
| Granted 148,456 options to buy
@ $74.31, valued at
$11M
|
|
| 04/04/2023 |
4
| Finke Daniel P (EVP/Pres, Health Care Benefits) has filed a Form 4 on CVS HEALTH Corp|
Txns:
| Paid exercise price by delivering 3,856 shares
@ $74.31, valued at
$286.5k
Granted 74,228 options
@ $74.31, valued at
$5.5M
|
|
| 04/04/2023 |
4
| Clark James David (SVP, Cont & Chief Acct Officer) has filed a Form 4 on CVS HEALTH Corp|
Txns:
| Paid exercise price by delivering 1,471 shares
@ $74.31, valued at
$109.3k
Granted 2,186 shares
@ $74.31, valued at
$162.4k
Granted 9,649 options
@ $74.31, valued at
$717k
|
|
| 04/04/2023 |
4
| Chaguturu Sreekanth K (EVP and Chief Medical Officer) has filed a Form 4 on CVS HEALTH Corp|
Txns:
| Paid exercise price by delivering 1,854 shares
@ $74.31, valued at
$137.8k
Granted 40,825 options
@ $74.31, valued at
$3M
|
|
| 03/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2023 |
4
| PELUSO MICHELLE A (EVP and Co-President of Retail) has filed a Form 4 on CVS HEALTH Corp|
Txns:
| Paid exercise price by delivering 12,304 shares
@ $85.77, valued at
$1.1M
|
|
| 03/01/2023 |
4
| Khichi Samrat S. (EVP, CPO and General Counsel) has filed a Form 4 on CVS HEALTH Corp|
Txns:
| Granted 47,881 shares
@ $83.54, valued at
$4M
|
|
| 03/01/2023 |
4
| Joyner J. David (EVP&President-PharmacyServices) has filed a Form 4 on CVS HEALTH Corp|
Txns:
| Granted 23,940 shares
@ $83.54, valued at
$2M
|
|
| 03/01/2023 |
4
| Havanec Laurie P. (EVP and Chief People Officer) has filed a Form 4 on CVS HEALTH Corp|
Txns:
| Paid exercise price by delivering 4,046 shares
@ $85.77, valued at
$347k
|
|
| 03/01/2023 |
4
| Clark James David (SVP, Cont & Chief Acct Officer) has filed a Form 4 on CVS HEALTH Corp|
Txns:
| Paid exercise price by delivering 179 shares
@ $83.54, valued at
$15k
|
|
| 03/01/2023 |
4
| Chaguturu Sreekanth K (EVP and Chief Medical Officer) has filed a Form 4 on CVS HEALTH Corp|
Txns:
| Paid exercise price by delivering 318 shares
@ $85.77, valued at
$27.3k
Paid exercise price by delivering 120 shares
@ $83.54, valued at
$10k
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|